Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4176
Nautilus Biotechnolgy
NAUT
$303M
| $101K | ﹤0.01% |
70,877
+37,131
| +110% | +$44.1K |
2026 Q2
1 quarter
|
|
4177
Huntsman Corp
HUN
$1.69B
| $100K | ﹤0.01% |
+11,949
| New | +$123K |
2026 Q3
0 quarters
|
|
4178
VTEX
VTEX
$642M
| $100K | ﹤0.01% |
+27,474
| New | +$106K |
2026 Q3
0 quarters
|
|
4179
SANUWAVE Health Inc
SNWV
$13.6M
| $100K | ﹤0.01% |
21,243
+3,000
| +16% | +$18K |
2026 Q2
1 quarter
|
|
4180
Ideal Power
IPWR
$36M
| $100K | ﹤0.01% |
+25,382
| New | +$112K |
2026 Q3
0 quarters
|
|
4181
Mobia Medical
MOBI
$443M
| $100K | ﹤0.01% |
+10,532
| New | +$119K |
2026 Q3
0 quarters
|
|
4182
CoinShares PLC
CSHR
$473M
| $99.3K | ﹤0.01% |
+19,982
| New | +$100K |
2026 Q3
0 quarters
|
|
4183
Corbus Pharmaceuticals
CRBP
$70.3M
| $97K | ﹤0.01% |
+14,218
| New | +$131K |
2026 Q3
0 quarters
|
|
4184
United States Antimony
UAMY
$436M
| $96.4K | ﹤0.01% |
23,121
-307,157
| -93% | -$1.68M |
2025 Q4
3 quarters
|
|
4185
CALL
Quantum Computing Inc
QUBT
$1.32B
| $95.5K | ﹤0.01% |
+11,300
| New | +$95.3K |
2026 Q3
0 quarters
|
|
4186
Neonode
NEON
$10.6M
| $95.2K | ﹤0.01% |
106,452
+15,686
| +17% | +$13.7K |
2026 Q1
2 quarters
|
|
4187
Oramed Pharmaceuticals
ORMP
$168M
| $95K | ﹤0.01% |
+20,353
| New | +$92K |
2026 Q3
0 quarters
|
|
4188
PUT
Snap
SNAP
$9.01B
| $95K | ﹤0.01% |
17,600
-56,300
| -76% | -$291K |
2020 Q4
23 quarters
|
|
4189
AdvisorShares Pure US Cannabis ETF
MSOS
$716M
| $94.2K | ﹤0.01% |
+20,840
| New | +$97.7K |
2026 Q3
0 quarters
|
|
4190
T1 Energy
TE
$590M
| $92.9K | ﹤0.01% |
24,055
-1,404,972
| -98% | -$7.24M |
2025 Q4
3 quarters
|
|
4191
CALL
Enovix
ENVX
$395M
| $92.5K | ﹤0.01% |
31,900
-5,700
| -15% | -$22.3K |
2023 Q3
12 quarters
|
|
4192
SBC Medical Group
SBC
$549M
| $91.2K | ﹤0.01% |
+18,461
| New | +$69.1K |
2026 Q3
0 quarters
|
|
4193
Noah Holdings
NOAH
$452M
| $90.7K | ﹤0.01% |
11,463
-1,055
| -8% | -$9.09K |
2025 Q3
4 quarters
|
|
4194
Immuneering
IMRX
$238M
| $90.3K | ﹤0.01% |
22,063
-35,626
| -62% | -$168K |
2025 Q4
3 quarters
|
|
4195
Context Therapeutics
CNTX
$18.2M
| $89.7K | ﹤0.01% |
298,482
+245,773
| +466% | +$121K |
2026 Q2
1 quarter
|
|
4196
CALL
Sable Offshore Corp
SOC
$129M
| $89.3K | ﹤0.01% |
25,800
-245,200
| -90% | -$1.09M |
2025 Q2
5 quarters
|
|
4197
Portillo's
PTLO
$486M
| $88.2K | ﹤0.01% |
24,978
-106,910
| -81% | -$474K |
2022 Q4
15 quarters
|
|
4198
Lifetime Brands
LCUT
$177M
| $87.1K | ﹤0.01% |
10,129
-4,333
| -30% | -$38.1K |
2026 Q2
1 quarter
|
|
4199
Commercial Vehicle Group
CVGI
$140M
| $86.8K | ﹤0.01% |
29,629
-4,935
| -14% | -$18.3K |
2026 Q2
1 quarter
|
|
4200
AMC Entertainment Holdings
AMC
$2.98B
| $85.7K | ﹤0.01% |
+28,563
| New | +$71.1K |
2026 Q3
0 quarters
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.